Audience: Australian adults over 30 who are tired of sleepless nights, low mood, stress-related overeating, and the fog that comes with sedative sleeping pills.
If you are over 30, you may already know the pattern: you go to bed exhausted, but your brain will not switch off. You wake at 2 a.m., worrying about work, family, finances, or health. The next day you feel groggy, irritable, forgetful, and reach for sugar or caffeine. Some nights you might use a sleeping pill or alcohol, but over time those can stop working, leave you hungover, cause dependence, and increase falls or memory problems.
In my clinical practice, many Australian patients tell me they want “something that helps me sleep, lifts my mood, and does not turn me into a zombie.” That is exactly the gap where trazodone can fit.
Trazodone is a prescription-only antidepressant from the serotonin antagonist and reuptake inhibitor (SARI) class. It has been used for decades and is well known in Australia for its dual action: at low doses it is strongly sedating and helps initiate and maintain sleep; at higher doses it treats major depression and anxiety. Unlike some older sedatives, it is not a benzodiazepine and has a low risk of dependence when used as prescribed.
| Feature | Detail |
|---|---|
| Drug class | Serotonin antagonist and reuptake inhibitor (SARI) |
| Common Australian uses | Major depression, anxiety, insomnia (off-label at low dose), adjunct in inpatient psychiatry |
| Usual sleep dose | 25–100 mg at night |
| Usual antidepressant dose | 150–300 mg/day, sometimes up to 600 mg/day under specialist care |
| Onset for sleep | Often within 30–60 minutes after an evening dose |
| Half-life in serum | Around 5–13 hours; most drug cleared in 1–2 days |
| PBS status | PBS listing may be available for major depressive disorder; private prescriptions may also apply |
Bulimia nervosa is not simply about food; it is often driven by emotional dysregulation, anxiety, impulsivity, and disturbed sleep. Night-time binge-purge cycles can worsen when insomnia leaves the brain craving soothing foods. Trazodone is not a first-line treatment for bulimia, but many Australian psychiatrists use it as an adjunct. By improving sleep, lowering anxiety, and stabilising mood, it can reduce the urge to binge late at night and make psychological therapy more effective. In my experience, patients over 30 with bulimia often say that once their sleep and evening anxiety improve, their eating behaviour becomes far easier to control.
Patients often ask, “Will this show up on a blood test?” The answer is that when specifically tested for, trazodone can be detected in serum. The drug has a half-life of approximately 5–13 hours, so after a single dose most is cleared within one to two days. In routine clinical practice, therapeutic drug monitoring is not usually required. However, if your doctor orders a serum drug screen or is checking adherence or possible toxicity, trazodone may be detectable for around 1–3 days after the last dose depending on the dose, duration, and laboratory method. This relatively short detection window is reassuring because it means the medication does not build up excessively in the body when used correctly.
Low folate levels are common in people with long-standing depression, poor diet, alcohol use, or high stress. Folate is needed for the brain to make serotonin, dopamine, and noradrenaline. In Australia, some doctors now check folate and use L-methylfolate, the active form of folate, as an add-on treatment. When combined with trazodone, methylfolate augmentation may improve the antidepressant response, particularly in patients who have only partially responded to an antidepressant alone. This can be especially relevant for adults over 30 who have busy lives, poor eating patterns, or genetic variations in folate metabolism.
In many Australian public and private psychiatric units, trazodone has become a preferred non-benzodiazepine option for patients who need help sleeping and settling at night. Hospital protocols often favour low-dose trazodone over benzodiazepines because it does not carry the same addiction potential and it helps treat the underlying mood disorder. Inpatients with depression, anxiety, borderline personality traits, or substance-use histories are often prescribed trazodone at night to improve sleep, reduce agitation, and support the overall treatment plan. This real-world use in Australian hospitals confirms its safety and tolerability when used appropriately.
Electroconvulsive therapy remains one of the most effective treatments for severe, treatment-resistant depression. Many patients worry about how their medications will interact with ECT. Trazodone has a relatively low risk of interfering with seizure quality compared with some older antidepressants, and in many Australian ECT units it is continued at a low dose at night for sleep and agitation. This can reduce pre-ECT anxiety and improve post-ECT rest. However, every ECT protocol is individualised, so your treating psychiatrist will decide whether to continue, reduce, or temporarily withhold trazodone around ECT sessions. Do not change your dose without specialist advice.
Yes. In fact, taking trazodone with food or shortly after a light meal is recommended. Food slows the absorption slightly, which can reduce nausea and dizziness, especially when you first start treatment. Taking it with food also improves the steady release of medicine overnight. For busy Australians over 30, a practical routine is to take trazodone with a small evening snack, such as yoghurt or a piece of toast, about 30–60 minutes before bed. Avoid a heavy, high-fat meal right before dosing because it may delay the onset of sleepiness.
This is one of the most common questions I hear. In the short term, starting trazodone or taking too high a night-time dose can cause a mild “hangover” feeling and temporary fogginess the next morning. This usually settles within days to weeks. In the long term, however, trazodone often improves memory and concentration because it restores deep sleep and treats depression. Chronic insomnia and depression themselves are major causes of poor memory. Many patients over 30 say their memory improves once they are sleeping through the night and their mood lifts.
This is a crucial safety point. Trazodone should not be casually combined with other sedatives. Mixing trazodone with benzodiazepines such as diazepam or temazepam, z-drugs such as zolpidem or zopiclone, antihistamines, opioids, or alcohol can cause excessive sedation, low blood pressure, confusion, falls, and in severe cases respiratory depression. If you are already taking a sleeping pill, your doctor may need to reduce its dose or withdraw it slowly before adding trazodone. Never combine sedatives without explicit medical advice.
| Question | Practical answer |
|---|---|
| Take with food? | Yes, with a light snack; reduces nausea and dizziness. |
| How long in blood? | Mostly cleared in 1–2 days; detectable about 1–3 days in serum. |
| Good with methylfolate? | Often yes; discuss folate testing with your GP. |
| Used in hospital? | Yes, common in Australian psychiatric wards for sleep and agitation. |
| Safe with ECT? | Often continued at low dose, but psychiatrist must decide. |
| Memory effects | May briefly impair next-day alertness at start; usually improves memory long-term by restoring sleep and mood. |
| With sleeping pills? | Do not mix without medical review; additive sedation risk. |
| Help with bulimia? | Adjunct benefit by reducing night-time anxiety, insomnia, and impulsivity. |
If you are over 30 and tired of living with broken sleep, low mood, evening cravings, or daytime fog, trazodone may be worth discussing with your doctor. It is a well-established, PBS-listed prescription medicine in Australia, often more affordable than newer brands, and it gives many patients a gentle, non-addictive option for sleep and mood. Whether you are struggling with bulimia nervosa, considering ECT, or simply want to reduce your reliance on sleeping pills, trazodone deserves a place in the conversation.
To access trazodone in Australia:
This article is for educational review and reflects clinical experience. Individual treatment decisions must always be made with a qualified Australian prescriber.